Top Back to top

HSCT experience in patients with Interferon gamma receptor deficiencies

Inborn Errors Working Party (IEWP)
Study type:
Study number:
Type of Stem Cell Treatment:
Short title:
Primary objective:
Key inclusion criteria:
Inclusion criteria: only patients with a molecular diagnosis of IFNGR1/2 deficiency (including both complete and partial defects) AND treated with HSCT (including those patients who died during the procedure) will be eligible
Principal investigator:
Peter Olbrich
EBMT Study coordinator:
Sheree Hazelaar & Henric-Jan Blok
Study coordinator email: